Genetic inhibition of IRE1α or XBP1 (X-box-binding protein 1, a direct target of IRE1α, activated by mRNA cleavage) inhibits prostate cancer growth in vitro and in vivo [284,285]. The gene discussed is ERN1; the disease is prostate carcinoma.